Studies on the etiology, pathology, and potential therapeutic interventions for Insulin Dependent Diabetes Mellitus (IDDM) have been greatly assisted by the availability of a suitable animal model, the BB-WOR diabetic rat. This model has been difficult to establish and produce. The project objectives of this contract are to continue a centralized and stable source of supply of the BB Wor diabetic rat, a cost-reimbursement system for the distribution of these animals, and the development of genetically homogeneous familial lines with and without the diabetic defect.
Ellerman, K E; Like, A A (2000) Susceptibility to diabetes is widely distributed in normal class IIu haplotype rats. Diabetologia 43:890-8 |
Ellerman, K E; Like, A A (1999) Islet cell membrane antigens activate diabetogenic CD4+ T-cells in the BB/Wor rat. Diabetes 48:975-82 |
Ellerman, K E; Richards, C A; Guberski, D L et al. (1996) Kilham rat triggers T-cell-dependent autoimmune diabetes in multiple strains of rat. Diabetes 45:557-62 |
Ellerman, K E; Like, A A (1995) A major histocompatibility complex class II restriction for BioBreeding/Worcester diabetes-inducing T cells. J Exp Med 182:923-30 |
Stubbs, M; Guberski, D L; Like, A A (1994) Preservation of GLUT 2 expression in islet beta cells of Kilham rat virus (KRV)-infected diabetes-resistant BB/Wor rats. Diabetologia 37:1186-94 |
Guberski, D L; Butler, L; Manzi, S M et al. (1993) The BBZ/Wor rat: clinical characteristics of the diabetic syndrome. Diabetologia 36:912-9 |